Scholars Central

ArticlePublished 28 Oct 2022

Breast Cancer Treatment Using Liposome Technology

Authors: Mattia Tiboni

Annals of Clinical Trials and Vaccines Research

Volume 12 · Issue 5 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The therapeutic index of anticancer medications that are not otherwise encapsulated can theoretically be improved by liposome-based chemotherapy used to treat breast cancer. This is partly explained by the fact that liposomes’ ability to deliver higher medication concentrations to the tumour site enables the encapsulation of cytotoxic drugs. The phospholipid bilayer also aids to limit exposure of the drug to healthy sensitive tissue and prevents the encapsulated active form of the drug from being broken down in the body before reaching tumour tissue. Despite the fact that clinically authorised liposomebased chemotherapeutics like Doxil have shown to be quite efficient in the treatment of breast cancer, serious problems with insufficient drug transfer between the liposome and cancer cells still exist. In this study, we talk about recent developments in the creation of chemotherapeutics based on liposomes that have improved drug transfer for use in the treatment of breast cancer.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Annals of Clinical Trials and Vaccines Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalAnnals of Clinical Trials and Vaccines Research
  • SubjectPharmaceutical Sciences
  • SubjectVaccines & Immunisation
  • BylineArticles whose byline prints “Mattia Tiboni”